Welcome to our dedicated page for Coherent SEC filings (Ticker: COHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Coherent Corp. (COHR) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Coherent is a Pennsylvania corporation listed on the New York Stock Exchange, and its filings give detailed insight into its operations as a global photonics company focused on materials, networking, and lasers for datacenter, communications, industrial, electronics, and instrumentation markets.
Through documents such as Form 10-K annual reports and Form 10-Q quarterly reports, investors can review Coherent’s segment information, including its Datacenter and Communications and Industrial segments, as well as historical references to Networking, Materials, and Lasers. These filings describe revenue drivers, cost structure, research and development spending, and risk factors related to its photonics and engineered materials businesses, including silicon carbide platforms and optical networking products.
Coherent’s Form 8-K current reports are particularly important for tracking material events. Recent 8-K filings have disclosed quarterly financial results, amendments to its credit agreement and term loans, the closing of the sale of its Aerospace and Defense business, a Waiver Agreement with the holder of its Series B-1 and Series B-2 Convertible Preferred Stock regarding dividends, and shareholder meeting results. These filings document changes in capital structure, debt refinancing, and corporate governance matters.
On this page, users can also access filings that relate to preferred equity, credit facilities, and other financing arrangements, as well as proxy-related disclosures on director elections, executive compensation advisory votes, and auditor ratification. Forms related to insider share transactions, such as Form 4, can be used to monitor trading activity by officers, directors, and significant shareholders.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, helping readers quickly understand segment performance, major agreements, and capital structure changes. Real-time updates from EDGAR ensure that new Coherent filings, including 10-Ks, 10-Qs, 8-Ks, and ownership reports, are available promptly, while AI-generated explanations make complex financial and legal language more accessible.
Coherent Corp: Schedule 13G/A amendment reporting disaggregated Vanguard holdings. The filing states that The Vanguard Group reports 0 shares beneficially owned of Common Stock, representing 0%. The disclosure explains an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries to report separately.
The form is signed by Ashley Grim as Head of Global Fund Administration on 03/26/2026. The filing reaffirms that no single outside person holds more than 5% of the class in Vanguard’s reported accounts.
Coherent Corp. director Howard H. Xia reported a combination of option exercises and share sales. On March 16–17, 2026, he exercised options to acquire a total of 4,240 shares of common stock at an exercise price of $21.67 per share.
Across the same two days, he sold 4,240 common shares in open-market transactions at prices of $258.00, $245.57, $244.46, and $236.22 per share. After these transactions, he directly held 50,298 common shares. The exercised options were from a grant that vested in four equal annual installments beginning on August 17, 2017.
Howard H. Xia filed a Form 144 notice reporting a proposed sale of 3,240 shares of common stock on 03/17/2026 following an exercise of options under a registered plan. The filing also discloses a prior sale of 1,000 shares on 03/16/2026 for $258,000.
COHERENT CORP. Chief Technology Officer Julie Sheridan Eng reported an open-market sale of 1,454 shares of Common Stock on March 10, 2026 at an average price of $258.18 per share. After this transaction, she directly holds 49,436 shares. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2025, indicating it was scheduled in advance rather than timed discretionarily.
Coherent Corp. director Stephen A. Skaggs sold 3,523 shares of Common Stock in an open-market transaction. The sale occurred on March 9, 2026 at a weighted average price of $243.1309 per share, based on multiple trades between $237.90 and $250.00.
The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on December 3, 2025, indicating it was scheduled in advance. Following this sale, Skaggs directly holds 16,864 shares of Coherent Corp. common stock.
COHR affiliate filed a Form 144 notifying a proposed sale of 1,454 shares of Common Stock. The filing lists the broker as Morgan Stanley Smith Barney LLC and records shares outstanding were 187,481,852 as of 03/10/2026. The excerpt also reports 10b5-1 sales on 03/02/2026 of 2,792 shares for $813,646.04, and references an Employee Stock Purchase Plan dated 01/31/2023.
COHERENT CORP. director Enrico Digirolomo exercised stock options and then reduced his common share holdings through a sale and a charitable gift. On March 6, 2026, he exercised options for 1,005 and 2,906 shares of common stock. He then sold 3,911 common shares in an open-market transaction at $241.50 per share and made a bona fide gift of 1,847 shares to a donor advised fund. After these transactions, he directly owned 15,599 shares of Coherent common stock.
COHR notice of proposed sale of common stock under Rule 144 dated 03/06/2026. The filing lists dispositions tied to exercise of options under a registered plan and shows two share line items: 2,906 and 1,005, both dated 03/06/2026.
The transaction is reported through Morgan Stanley Smith Barney LLC as the broker/custodian. The form documents securities to be sold and related broker information; timing and final sale execution are not detailed in the excerpt.